Vaccines on order
Turkey currently uses 4 different COVID-19 vaccines. [5] [6]
| Vaccine | Approval | Deployment |
|---|---|---|
| Pfizer–BioNTech |  | |
| Sinovac | | |
| Sputnik V | | |
| TurkoVac | | |
| Date | 14 January 2021 – present |
|---|---|
| Location | Turkey |
| Cause | COVID-19 pandemic |
| Target | Full immunisation of people in Turkey against COVID-19 |
| Participants | 53024115 people completely vaccinated (9 November 2023) [1] |
| Website | covid19asi |
The COVID-19 vaccination campaign in Turkey began on January 14, 2021. [2] As of April 2nd, 2022, 57,784,362 people have received their first dose, and 52,982,877 people have been fully vaccinated. [1] 27,648,857 people received their third dose. [1] 63% of the total population in Turkey is fully vaccinated.
In January 2021, new COVID-19 cases in Turkey were at 12,203. Then, in April 2021, they rose to 40,806. However, due to the vaccine rollout, cases dropped to 5,288 in July 2021. [3]
Through a study done on the population of Turkey's perception of the COVID-19 vaccine, it was shown that only 62.7% of participants had a positive perception of the vaccine. Specifically, those with previous experience with COVID-19, those with bachelor's degrees or higher, and those with experience with influenza vaccines were more likely to have a positive perception of the COVID-19 vaccine. Older people were more likely to have a negative perception of the vaccine. [4]
Turkey currently uses 4 different COVID-19 vaccines. [5] [6]
| Vaccine | Approval | Deployment |
|---|---|---|
| Pfizer–BioNTech | | |
| Sinovac | | |
| Sputnik V | | |
| TurkoVac | | |
New vaccination per day 7-day moving average
 | Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org. |
First dose Second dose
| Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org. |
First dose Second dose
| Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org. |
CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.
COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The virus causing COVID-19 was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.
COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.
COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.
Vaccination in Mexico includes the use of vaccines in advancing public health. Mexico has a multi-year program for immunization of children. The immunization of children is fully covered by the government of Mexico. Mexico has an adverse events committee to monitor the adverse effects of vaccination as well as a standing technical advisory group on immunization.
The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.
COVID-19 vaccination in Norway is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 3 January 2022 79,5% of the population have been vaccinated with the first dose, 72,7% with the second dose and 28,8% with the third dose.
The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population having completed their vaccination regimen.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.
COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.
The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.
 | This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. |
 | This Turkey-related article is a stub. You can help Wikipedia by expanding it. |
